Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学H3K9me3, Heterochromatin and Cancer

Thomas Jenuwein

PhD

🏢Max Planck Institute of Immunobiology and Epigenetics🌐Germany

Director

85
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Thomas Jenuwein co-discovered the first histone lysine methyltransferase SUV39H1, demonstrating that histone H3K9 methylation recruits heterochromatin protein 1 (HP1) to establish constitutive heterochromatin, a discovery that opened the entire field of histone methylation enzymology. His work showed that loss of H3K9me3 and heterochromatin destabilization causes genomic instability through derepression of pericentromeric satellite repeats and transposable elements, contributing to chromosome segregation errors and cancer predisposition. He has established that H3K9 methylation safeguards genome integrity by maintaining repeat element silencing. His conceptual and experimental contributions to histone methylation biology earned him the Gruber Prize in Genetics.

Share:

🧪Research Fields 研究领域

H3K9 methyltransferase SUV39H1
heterochromatin formation HP1
histone lysine methylation discovery
pericentromeric heterochromatin genome stability
epigenetic silencing repeat elements cancer

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Thomas Jenuwein 的研究动态

Follow Thomas Jenuwein's research updates

留下邮箱,当我们发布与 Thomas Jenuwein(Max Planck Institute of Immunobiology and Epigenetics)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment